
Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …

Biofrontera AG has announced the European Commission has approved the use of their drug Ameluz in combination with photodynamic therapy …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

